Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combinatorial Strategies for the Induction of Immunogenic Cell Death
Lucillia Bezu, Ligia C. Gomes-de-Silva, Heleen Dewitte, et al.
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 378

Showing 1-25 of 378 citing articles:

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
Lorenzo Galluzzi, Ilio Vitale, Stuart A. Aaronson, et al.
Cell Death and Differentiation (2018) Vol. 25, Iss. 3, pp. 486-541
Open Access | Times Cited: 5383
The biology and management of non-small cell lung cancer
Roy S. Herbst, Daniel Morgensztern, Chris Boshoff
Nature (2018) Vol. 553, Iss. 7689, pp. 446-454
Closed Access | Times Cited: 3825
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi, Aitziber Buqué, Oliver Kepp, et al.
Nature reviews. Immunology (2016) Vol. 17, Iss. 2, pp. 97-111
Closed Access | Times Cited: 2454
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
Lorenzo Galluzzi, Aitziber Buqué, Oliver Kepp, et al.
Cancer Cell (2015) Vol. 28, Iss. 6, pp. 690-714
Open Access | Times Cited: 1361
Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types?
Carlos Rosales
Frontiers in Physiology (2018) Vol. 9
Open Access | Times Cited: 1100
IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance
David H. Munn, Andrew L. Mellor
Trends in Immunology (2016) Vol. 37, Iss. 3, pp. 193-207
Open Access | Times Cited: 869
Detection of immunogenic cell death and its relevance for cancer therapy
Jitka Fučíková, Oliver Kepp, Lenka Kašíková, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 11
Open Access | Times Cited: 758
Autophagy, Inflammation, and Immunity: A Troika Governing Cancer and Its Treatment
Zhenyu Zhong, Elsa Sánchez‐López, Michael Karin
Cell (2016) Vol. 166, Iss. 2, pp. 288-298
Open Access | Times Cited: 548
Immune suppressive mechanisms in the tumor microenvironment
David H. Munn, Vincenzo Bronte
Current Opinion in Immunology (2015) Vol. 39, pp. 1-6
Open Access | Times Cited: 456
Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression
Jianqin Lu, Xiangsheng Liu, Yu‐Pei Liao, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 408
Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses
Abhishek D. Garg, Patrizia Agostinis
Immunological Reviews (2017) Vol. 280, Iss. 1, pp. 126-148
Open Access | Times Cited: 376
Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy
Tianyu Tang, Xing Huang, Gang Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 365
Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
Abhishek D. Garg, Lorenzo Galluzzi, Lionel Apétoh, et al.
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 352
Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMP
Yi Zhou, Mingjian Fei, Gu Zhang, et al.
Immunity (2020) Vol. 52, Iss. 2, pp. 357-373.e9
Open Access | Times Cited: 321
Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy
Hathaichanok Phuengkham, Long Ren, Il-Woo Shin, et al.
Advanced Materials (2019) Vol. 31, Iss. 34
Closed Access | Times Cited: 259
Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant
Chang Yang, Bairong Xia, Zhao-Cong Zhang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 249
Mechanisms of immune evasion in breast cancer
Joshua P. Bates, Roshanak Derakhshandeh, Laundette P. Jones, et al.
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 236
Immunogenic cell death in anticancer chemotherapy and its impact on clinical studies
Qiang Wang, Xiaoli Ju, Jiayou Wang, et al.
Cancer Letters (2018) Vol. 438, pp. 17-23
Closed Access | Times Cited: 230
Janus Nanobullets Combine Photodynamic Therapy and Magnetic Hyperthermia to Potentiate Synergetic Anti‐Metastatic Immunotherapy
Zheng Wang, Fan Zhang, Dan Shao, et al.
Advanced Science (2019) Vol. 6, Iss. 22
Open Access | Times Cited: 230
Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity
Mikako Ogawa, Yusuke Tomita, Yuko Nakamura, et al.
Oncotarget (2017) Vol. 8, Iss. 6, pp. 10425-10436
Open Access | Times Cited: 223
Targeting the DNA damage response in immuno-oncology: developments and opportunities
Roman M. Chabanon, Mathieu Rouanne, Christopher J. Lord, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 11, pp. 701-717
Closed Access | Times Cited: 215
Combining DNA damaging therapeutics with immunotherapy: more haste, less speed
Jessica Brown, Raghav Sundar, Juanita Lopez
British Journal of Cancer (2017) Vol. 118, Iss. 3, pp. 312-324
Open Access | Times Cited: 214
Frontiers in the treatment of glioblastoma: Past, present and emerging
Taskeen Iqbal Janjua, Prarthana Rewatkar, Aria Ahmed-Cox, et al.
Advanced Drug Delivery Reviews (2021) Vol. 171, pp. 108-138
Closed Access | Times Cited: 203
Tipping the immunostimulatory and inhibitory DAMP balance to harness immunogenic cell death
Kazukuni Hayashi, Fotis Nikolos, Y. C. Lee, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 200
Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy
Yiyi Yan, Anagha Kumar, Heidi D. Finnes, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 197
Page 1 - Next Page

Scroll to top